Description
A potent inhibitor of the generation of phosphatidic acid (IC50 = 0.6 µM) from cytokine-activated lysophosphatidic acyl transferase (LPAAT), which has been shown to protect mice from endotoxic shock; suppresses the production of the proinflammatory cytokine IFN-γ, inhibits IL-12 signaling, and enhances glucose-stimulated β-cell insulin secretion; reduces the onset of diabetes in a non-obese diabetic mouse model
Formal name: 3,7-dihydro-1-[(5R)-5-hydroxyhexyl]-3,7-dimethyl-1H-purine-2,6-dione
Synonyms: (−)-Lisofylline|(R)-LSF
Molecular weight: 280.3
CAS: 100324-81-0
Purity: ≥97%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Acyltransferases||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Immunology & Inflammation|Innate Immunity|Sepsis/Shock